Clinical Trial Update: Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors [Phase 1]

View source ↗

Summary

This Phase 1 study assesses the safety, tolerability, pharmacokinetics, and preliminary efficacy of BAT6005 in patients with locally advanced or metastatic soli…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Or Metastatic Solid Tumors

Drugs mentioned

• BAT6005 (BAT6005)

Snippet

Sponsor: Bio-Thera Solutions | Conditions: Locally Advanced or Metastatic Solid Tumors | Phase 1 | Status: COMPLETED